Action Potential Venture Capital
Suraj Mudichintala is a seasoned professional in investment and consulting, currently serving as a Senior Associate at Action Potential Venture Capital since June 2022, focusing on investments that integrate engineering, biology, and computation. Previously, Mudichintala was an Associate at Arboretum Ventures from December 2018 to June 2022, leading due diligence on investments. Prior experience includes roles as an Analyst at L.E.K. Consulting and a Commercial Advisory Intern at EY, where operations, compliance, and risk management were key focuses. Mudichintala began career experiences as an Assembly Product Intern at LSI Corporation and an Office Manager at a primary care clinic. Academically, Mudichintala holds a degree in Management, Finance, and Business Analytics from Boston College, obtained in 2016.
This person is not in any teams
This person is not in any offices
Action Potential Venture Capital
Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices and invests in companies and technologies that enable the future of targeted and adaptive bioelectronics.